Campbell & Co Investment Adviser’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-24,641
| Closed | -$139K | – | 1361 |
|
|
2024
Q2 | $139K | Sell |
24,641
-44,042
| -64% | -$249K | 0.01% | 988 |
|
|
2024
Q1 | $282K | Buy |
68,683
+30,661
| +81% | +$126K | 0.02% | 929 |
|
|
2023
Q4 | $160K | Buy |
38,022
+12,186
| +47% | +$51.4K | 0.01% | 1043 |
|
|
2023
Q3 | $112K | Sell |
25,836
-19,175
| -43% | -$82.8K | 0.01% | 894 |
|
|
2023
Q2 | $297K | Buy |
+45,011
| New | +$297K | 0.05% | 670 |
|
|
2022
Q3 | – | Sell |
-11,803
| Closed | -$129K | – | 958 |
|
|
2022
Q2 | $129K | Buy |
11,803
+1,303
| +12% | +$14.2K | 0.03% | 636 |
|
|
2022
Q1 | $119K | Buy |
+10,500
| New | +$119K | 0.03% | 660 |
|
|
2021
Q2 | – | Sell |
-12,100
| Closed | -$182K | – | 730 |
|
|
2021
Q1 | $182K | Buy |
+12,100
| New | +$182K | 0.11% | 369 |
|
|
2020
Q1 | – | Sell |
-15,137
| Closed | -$248K | – | 515 |
|
|
2019
Q4 | $248K | Buy |
+15,137
| New | +$248K | 0.08% | 502 |
|